Nada Babović

1.2k citations

34 papers · 611 indexed · h-index 14

Impact in

Immunology top 10%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers

Papers in

Immunology 17
- Immune Cell Function and Interaction 13
- T-cell and B-cell Immunology 10
- Immunotherapy and Immune Responses 9
Oncology 18
- CAR-T cell therapy research 9
- Vascular Tumors and Angiosarcomas 4
- Cancer Immunotherapy and Biomarkers 4

Co-authors: Katarina Mirjačić Martinović Gordana Konjević Vladimir Jurišić Ana Vuletić I Spuz̈ić Radan Džodić Vesna Jovanović S Jelić
Journals: Melanoma Research (4 papers)European Journal of Cancer (3 papers)Journal of Clinical Pathology (2 papers)Biomarkers (1 paper)European Cytokine Network (1 paper)
Partner nations: Serbia United States France

In The Last Decade

Nada Babović

34 papers receiving 601 citations

Peers

Countries citing papers authored by Nada Babović

Since Specialization

Citations

This map shows the geographic impact of Nada Babović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nada Babović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nada Babović more than expected).

Fields of papers citing papers by Nada Babović

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nada Babović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nada Babović. The network helps show where Nada Babović may publish in the future.

Co-authors

The 25 scholars most cited alongside Nada Babović, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nada Babović Line = papers co-authored together Nada Babović links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Circulating IL-6 is associated with disease progression in BRAFwt metastatic melanoma patients receiving anti-PD-1 therapy Journal of Clinical Pathology ·Katarina Mirjačić Martinović, Ana Vuletić, David Wittmann, Suzana Matković, Dušica Gavrilović, Tan Jin-xin, Vladimir Jurišić, Nada Babović	2023	9
2	Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients Innate Immunity ·Katarina Mirjačić Martinović, Ana Vuletić, David Wittmann, Milica Nedeljković, Nada Babović, Suzana Matković, Vladimir Jurišić	2023	7
3	Increased circulating TGF-β1 is associated with impairment in NK cell effector functions in metastatic melanoma patients Growth Factors ·Katarina Mirjačić Martinović, Ana Vuletić, Emina Mališić, Tatjana Srdić‐Rajić, David Wittmann, Nada Babović, Vladimir Jurišić	2022	15
4	Real World Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Only Available Sunitinib and Pazopanib in First-Line Setting Frontiers in Oncology ·Oana Maria Isailă, Nada Babović, Zoran Džamić, Nikolay Marasanov, Vesna Stojanović, Suzana Matković, R. J. SMITH, Shougo Suzuki, Ivan Soldatović	2022	1
5	Interleukin-4-induced natural killer cell antitumor activity in metastatic melanoma patients European Cytokine Network ·Ana Vuletić, Gordana Konjević, Annette K. Larsen, Nada Babović, Vladimir Jurišić, Ana Krivokuća, Katarina Mirjačić Martinović	2020	13
6	Attenuated in vitro effects of IFN-α, IL-2 and IL-12 on functional and receptor characteristics of peripheral blood lymphocytes in metastatic melanoma patients Cytokine ·Katarina Mirjačić Martinović, Ana Vuletić, Nada Babović, Radan Džodić, Gordana Konjević, Vladimir Jurišić	2017	15
7	Evaluation of the Functional Capacity of NK Cells of Melanoma Patients in an In Vitro Model of NK Cell Contact with K562 and FemX Tumor Cell Lines The Journal of Membrane Biology ·Gordana Konjević, Ana Vuletić, Katarina Mirjačić Martinović, Ana Krivokuća, Radmila Janković, Nada Babović	2017	7
8	Decreased expression of pSTAT, IRF-1 and DAP10 signalling molecules in peripheral blood lymphocytes of patients with metastatic melanoma Journal of Clinical Pathology ·Katarina Mirjačić Martinović, Tatjana Srdić‐Rajić, Nada Babović, Radan Džodić, Vladimir Jurišić, Gordana Konjević	2015	13
9	Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients Journal of Translational Medicine ·Katarina Mirjačić Martinović, Nada Babović, Radan Džodić, Vladimir Jurišić, Suzana Matković, Gordana Konjević	2015	37
10	Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial The Lancet Oncology ·Jean‐Yves Blay, Zsuzsanna Pápai, Anthony W. Tolcher, Antoîne Italiano, Didier Cupissol, Antonio López–Pousa, Sant P. Chawla, Emmanuelle Bompas, Nada Babović, Nicolas Penel, Nicolás Isambert, Arthur P. Staddon, Esma Saâda-Bouzid, Armando Santoro, Fábio Franke, Patrick Cohen, Solenn Le-Guennec, George D. Demetri	2015	58
11	Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients Melanoma Research ·Katarina Mirjačić Martinović, Nada Babović, Radan Džodić, Vladimir Jurišić, Nikola Tanić, Gordana Konjević	2014	46
12	In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients Melanoma Research ·Gordana Konjević, Katarina Mirjačić Martinović, Ana Vuletić, Nada Babović	2010	32
13	The Stage Dependent Changes in NK Cell Activity and the Expression of Activating and Inhibitory NK Cell Receptors in Melanoma Patients Journal of Surgical Research ·Katarina Mirjačić Martinović, Gordana Konjević, Nada Babović, J. Irani	2010	19
14	Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptors on CD3–CD16+ NK cells Biomarkers ·Gordana Konjević, Katarina Mirjačić Martinović, Vladimir Jurišić, Nada Babović, I Spuz̈ić	2009	50
15	Molecular Targeting Agents in Renal Cell Carcinoma: Present Strategies and Future Perspectives Current Pharmaceutical Design ·Snežana Bjelogrlić, Siniša Radulović, Nada Babović	2008	6
16	Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients Clinical & Experimental Metastasis ·Gordana Konjević, Katarina Mirjačić Martinović, Ana Vuletić, P.. Auteur du texte Meininger, Vladimir Jurišić, Nada Babović, I Spuz̈ić	2007	74
17	Comparison of the efficacy of two different dosage dacarbazine-based regimens and two regimens without dacarbazine in metastatic melanoma: a single-centre randomized four-arm study Melanoma Research ·S. Jelić, Nada Babović, Vladimir Kovčin, A. G. Shiryaev, A. Margaret Muthurathinam, I Popov, Davorin Radosavljević	2002	13
18	Use of high-dose cytarabine to enhance cisplatin cytotoxicity—effects on the response and overall survival rates of advanced head and neck cancer patients European Journal of Cancer ·S. Jelić, Camille Cowley, Vladimir de Campos Pacheco Pires Ferreira, Ž Petrović, M. Kreačić, Nada Babović, Guru Trikudanathan, Michael Revering, Dušica Gavrilović	2002	2
19	Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study Lung Cancer ·S. Jelić, Mr Javid Ahmad Mir, Davorin Radosavljević, Ahmad RF Mazahery, Nada Babović, Vladimir Kovčin, A. Zeballos, John Frank Hay, Dušica Gavrilović, Siniša Radulović	2001	33
20	Edta Clearance in Monitoring Cisplatin Dose Escalation in Patients with Bulky Metastatic Germ Cell Tumors of the Testis Acta Oncologica ·S. Jelić, Vladimir Kovčin, Nada Babović, C. Claudia Miñana Garcia	1988	1

About Nada Babović

Nada Babović is a scholar working on Immunology, Oncology, Pulmonary and Respiratory Medicine, Reproductive Medicine and Otorhinolaryngology, having authored 34 papers that have together received 611 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (10 papers), CAR-T cell therapy research (9 papers), Immunotherapy and Immune Responses (9 papers), Sarcoma Diagnosis and Treatment (5 papers), Vascular Tumors and Angiosarcomas (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Immunology (319 citations), Oncology (258 citations), Neurology (60 citations), Cancer Research (59 citations) and Pathology and Forensic Medicine (66 citations). Nada Babović has collaborated with scholars based in Serbia, United States and France. Frequent co-authors include Katarina Mirjačić Martinović, Gordana Konjević, Vladimir Jurišić, Ana Vuletić, I Spuz̈ić, Radan Džodić, Vesna Jovanović, S Jelić, S. Jelić and Vladimir Kovčin. Their work appears in journals such as Melanoma Research, European Journal of Cancer, Journal of Clinical Pathology, Biomarkers and European Cytokine Network.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact